European Research Infrastructure on Highly Pathogenic Agents (International non-profit association)
European Research Infrastructure on Highly Pathogenic Agents is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0679.481.238. It was founded on 01-08-2017. Its registered office is in Ixelles. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 052 753 and a profit of € 113 901. These accounts report 10 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 14-10-2026.
Company information
Key figures of European Research Infrastructure on Highly Pathogenic Agents
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 113 901-76 % | € 473 212+198 % | € 158 952-36 % | € 248 541 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 2 052 753+6 % | € 1 938 851+32 % | € 1 465 640+12 % | € 1 306 688 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 7 596 361+17 % | € 6 471 840-43 % | € 11 311 536-18 % | € 13 798 388 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 1 083 266-21 % | € 1 366 116+31 % | € 1 044 933+6 % | € 986 636 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 10-9 % | 11+22 % | 9+20 % | 7.5 |
Financial estimate
Similar companies
Other companies in the same activity in Ixelles.
| Company | Town |
|---|---|
| S - CLINICA | 1050 Ixelles |
| European Medical Solutions | 1050 Ixelles |
| AZOR | 1050 Ixelles |
| BELGIAN INSTITUTE OF HUMAN RESEARCH | 1050 Ixelles |
| MULTIFACE | 1050 Ixelles |
| MK ENGINEERING | 1050 Ixelles |
| BESINS HEALTHCARE BENELUX | 1050 Ixelles |
| WYETH LEDERLE VACCINES | 1050 Ixelles |
Frequently asked questions
Is European Research Infrastructure on Highly Pathogenic Agents still active? Yes. The Crossroads Bank for Enterprises lists European Research Infrastructure on Highly Pathogenic Agents as active.
What is the VAT number of European Research Infrastructure on Highly Pathogenic Agents? The VAT number of European Research Infrastructure on Highly Pathogenic Agents is BE 0679.481.238.
When was European Research Infrastructure on Highly Pathogenic Agents founded? European Research Infrastructure on Highly Pathogenic Agents was founded on 01-08-2017.
What is the address of European Research Infrastructure on Highly Pathogenic Agents? The current registered office of European Research Infrastructure on Highly Pathogenic Agents is Rue du Trône 98, 1050 Ixelles.
When did European Research Infrastructure on Highly Pathogenic Agents last file annual accounts? The latest annual accounts of European Research Infrastructure on Highly Pathogenic Agents were filed on 27-08-2026.
Does European Research Infrastructure on Highly Pathogenic Agents file its annual accounts on time? Yes. European Research Infrastructure on Highly Pathogenic Agents filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does European Research Infrastructure on Highly Pathogenic Agents have? European Research Infrastructure on Highly Pathogenic Agents employs 10 full-time equivalents according to its most recent annual accounts.
Is European Research Infrastructure on Highly Pathogenic Agents financially healthy? Addrly gives European Research Infrastructure on Highly Pathogenic Agents a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is European Research Infrastructure on Highly Pathogenic Agents profitable? The annual accounts of European Research Infrastructure on Highly Pathogenic Agents for 2025 show a profit of € 113 901.
What is the equity of European Research Infrastructure on Highly Pathogenic Agents? The equity of European Research Infrastructure on Highly Pathogenic Agents was € 2 052 753 at the close of the 2025 financial year.
Who are the directors of European Research Infrastructure on Highly Pathogenic Agents? The annual accounts of European Research Infrastructure on Highly Pathogenic Agents record 17 mandates. The names, roles and dates are visible with a free account.
Can European Research Infrastructure on Highly Pathogenic Agents receive Peppol e-invoices? Yes. European Research Infrastructure on Highly Pathogenic Agents is registered on the Peppol network and can receive structured electronic invoices.
What does European Research Infrastructure on Highly Pathogenic Agents do? The main activity of European Research Infrastructure on Highly Pathogenic Agents is: Scientific research and development.